Sara Penquite, MD
Endocrinology, Diabetes & Metabolism · Tucson, AZNPI 1528591682
Payments from drug & device makers
Across 39 payments — averaging $104.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Insulet Corporation$389
- Dexcom, Inc.$371
- Corcept Therapeutics$345
- Chiesi USA, Inc.$325
- BETA Bionics, Inc.$139
- plus $421 from 4 others
What the payments were for
- Speaking & faculty fees$3258%
- Travel & lodging$1,27131%
- Food & beverage$2,49161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $2,099 |
| Insulet Corporation | 6 | $389 |
| Dexcom, Inc. | 8 | $371 |
| Corcept Therapeutics | 3 | $345 |
| Chiesi USA, Inc. | 1 | $325 |
| BETA Bionics, Inc. | 1 | $139 |
| Abbott | 1 | $132 |
| Amryt Pharma Holdings Ltd | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $118 |
| Tandem Diabetes Care, Inc. | 2 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,522
- MYCAPSSA$450
- iLet Bionic Pancreas$416
- Korlym$248
- Omnipod$220
- DEXCOM G6 TRANSMITTER$153
- Afinion 2$132
- GVOKE PFS$118
How this compares
$4,088 in reported general payments places this provider in the 55th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 77 | $89,066 |
| MounjaroTirzepatide | 57 | $81,659 |
| OzempicSemaglutide | 48 | $66,318 |
| JardianceEmpagliflozin | 25 | $35,422 |
| Teriparatide | 12 | $27,216 |
| FarxigaDapagliflozin Propanediol | 20 | $16,962 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $14,441 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $12,949 |
| Humalog Kwikpen U-100Insulin Lispro | 26 | $11,726 |
| HumalogInsulin Lispro | 32 | $9,510 |
| Gvoke Hypopen 2-PackGlucagon | 11 | $6,657 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 48 | $6,299 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 13 | $4,455 |
| Hydrocortisone | 47 | $2,537 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 14 | $2,486 |
Paid to pharmacies, not to this prescriber.
Other endocrinology, diabetes & metabolism in Tucson
- Muhammad SethiTucson$670K
- Karen HerbstTucson$200K
- Stephen ThomsonTucson$135K
- Nora BarsonyTucson$121K
- Juan GalvezTucson$30K
- Maria PosadasTucson$24K
- Dorota PucykTucson$15K
- Alexander ZwartTucson$13K
- Neda EbrahimiTucson$11K
- Craig StumpTucson$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.